Resmed Inc. [RMD] moved up 8.48: Why It’s Important

Resmed Inc. [NYSE: RMD] stock went on an upward path that rose over 8.48% on Thursday, amounting to a one-week price increase of more than 7.87%. The company report on January 24, 2024 at 4:05 PM that ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024.

Year-over-year revenue grows 12%, operating profit down 2%, non-GAAP operating profit up 20%.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Over the last 12 months, RMD stock dropped by -20.23%. The one-year Resmed Inc. stock forecast points to a potential upside of 7.4. The average equity rating for RMD stock is currently 1.78, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $27.41 billion, with 147.06 million shares outstanding and 145.91 million shares in the current float. Compared to the average trading volume of 1.05M shares, RMD stock reached a trading volume of 2463232 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Resmed Inc. [RMD]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RMD shares is $201.24 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RMD stock is a recommendation set at 1.78. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Morgan Stanley have made an estimate for Resmed Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 27, 2023.

The Average True Range (ATR) for Resmed Inc. is set at 5.63, with the Price to Sales ratio for RMD stock in the period of the last 12 months amounting to 6.09. The Price to Book ratio for the last quarter was 6.12, with the Price to Cash per share for the same quarter was set at 1.43. Price to Free Cash Flow for RMD in the course of the last twelve months was 28.48 with Quick ratio for the last quarter at 1.89.

RMD Stock Performance Analysis:

Resmed Inc. [RMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.87. With this latest performance, RMD shares gained by 8.72% in over the last four-week period, additionally sinking by -15.92% over the last 6 months – not to mention a drop of -20.23% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RMD stock in for the last two-week period is set at 67.65, with the RSI for the last a single of trading hit 70.69, and the three-weeks RSI is set at 65.61 for Resmed Inc. [RMD]. The present Moving Average for the last 50 days of trading for this stock 165.91, while it was recorded at 176.49 for the last single week of trading, and 183.66 for the last 200 days.

Insight into Resmed Inc. Fundamentals:

Resmed Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.89 and a Current Ratio set at 3.11.


With the latest financial reports released by the company, Resmed Inc. posted 1.68/share EPS, while the average EPS was predicted by analysts to be reported at 1.59/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 5.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RMD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Resmed Inc. go to 11.60%.

Resmed Inc. [RMD] Institutonal Ownership Details

The top three institutional holders of RMD stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in RMD stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in RMD stock with ownership which is approximately 5.8325%.